Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133


Transient detection of Chlamydial-specific Th1 memory cells in the peripheral circulation of women with history of Chlamydia trachomatis genital tract infection.

Vicetti Miguel RD, Reighard SD, Chavez JM, Rabe LK, Maryak SA, Wiesenfeld HC, Cherpes TL.

Am J Reprod Immunol. 2012 Dec;68(6):499-506. doi: 10.1111/aji.12008. Epub 2012 Aug 31.


The Predominant CD4+ Th1 Cytokine Elicited to Chlamydia trachomatis Infection in Women Is Tumor Necrosis Factor Alpha and Not Interferon Gamma.

Jordan SJ, Gupta K, Ogendi BM, Bakshi RK, Kapil R, Press CG, Sabbaj S, Lee JY, Geisler WM.

Clin Vaccine Immunol. 2017 Apr 5;24(4). pii: e00010-17. doi: 10.1128/CVI.00010-17. Print 2017 Apr.


Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.

Russell AN, Zheng X, O'Connell CM, Wiesenfeld HC, Hillier SL, Taylor BD, Picard MD, Flechtner JB, Zhong W, Frazer LC, Darville T.

J Infect Dis. 2016 Dec 15;214(12):1884-1892. Epub 2016 Oct 12.


Frequency of Chlamydia trachomatis-specific T cell interferon-γ and interleukin-17 responses in CD4-enriched peripheral blood mononuclear cells of sexually active adolescent females.

Barral R, Desai R, Zheng X, Frazer LC, Sucato GS, Haggerty CL, O'Connell CM, Zurenski MA, Darville T.

J Reprod Immunol. 2014 Jun;103:29-37. doi: 10.1016/j.jri.2014.01.002. Epub 2014 Feb 1.


Immunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatis.

Rey-Ladino J, Ross AG, Cripps AW.

Hum Vaccin Immunother. 2014;10(9):2664-73. doi: 10.4161/hv.29683. Review.


Primary and secondary immune responses of mucosal and peripheral lymphocytes during Chlamydia trachomatis infection.

Vats V, Agrawal T, Salhan S, Mittal A.

FEMS Immunol Med Microbiol. 2007 Mar;49(2):280-7.


Host immune responses to chlamydial inclusion membrane proteins B and C in Chlamydia trachomatis infected women with or without fertility disorders.

Gupta R, Srivastava P, Vardhan H, Salhan S, Mittal A.

Reprod Biol Endocrinol. 2009 Apr 28;7:38. doi: 10.1186/1477-7827-7-38.


Role of NK cells in early host response to chlamydial genital infection.

Tseng CT, Rank RG.

Infect Immun. 1998 Dec;66(12):5867-75.


Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.

Vicetti Miguel RD, Quispe Calla NE, Pavelko SD, Cherpes TL.

PLoS One. 2016 Sep 8;11(9):e0162445. doi: 10.1371/journal.pone.0162445. eCollection 2016.


Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile.

Picard MD, Bodmer JL, Gierahn TM, Lee A, Price J, Cohane K, Clemens V, DeVault VL, Gurok G, Kohberger R, Higgins DE, Siber GR, Flechtner JB, Geisler WM.

Clin Vaccine Immunol. 2015 Nov;22(11):1206-18. doi: 10.1128/CVI.00247-15. Epub 2015 Oct 7.


CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.

Meoni E, Faenzi E, Frigimelica E, Zedda L, Skibinski D, Giovinazzi S, Bonci A, Petracca R, Bartolini E, Galli G, Agnusdei M, Nardelli F, Buricchi F, Norais N, Ferlenghi I, Donati M, Cevenini R, Finco O, Grandi G, Grifantini R.

Infect Immun. 2009 Sep;77(9):4168-76. doi: 10.1128/IAI.00344-09. Epub 2009 Jul 13.


Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity.

Vicetti Miguel RD, Harvey SA, LaFramboise WA, Reighard SD, Matthews DB, Cherpes TL.

PLoS One. 2013;8(3):e58565. doi: 10.1371/journal.pone.0058565. Epub 2013 Mar 13.

Supplemental Content

Support Center